In a rat HFC diet-induced NASH model, attenuation of chymase activity by chymase inhibitor resulted in reductions in TGF-β level and fibrotic area in the liver (Miyaoka et al., 2017). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.